Al-Razi Medical Company (TADAWUL:9572)

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmacies	74.38M	61.35M	61.33M	52.39M	45.19M
Pharmacies Growth	21.24%	0.03%	17.07%	15.95%	-
Total	74.38M	61.35M	61.33M	52.39M	45.19M
Total Growth	21.24%	0.03%	17.07%	15.95%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Saudi Arabia	74.38M	61.35M	61.33M	52.39M	45.19M
Saudi Arabia Growth	21.24%	0.03%	17.07%	15.95%	-
Total	74.38M	61.35M	61.33M	52.39M	45.19M
Total Growth	21.24%	0.03%	17.07%	15.95%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 14, 2026

Data Sources Report a data error